# Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

> **NCT01613560** · PHASE2 · UNKNOWN · sponsor: **Tao OUYANG** · enrollment: 404 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** AI adjuvant therapy
- **DRUG:** AI+chemotherapy adjuvant therapy
- **DRUG:** AI adjuvant therapy

## Key facts

- **NCT ID:** NCT01613560
- **Lead sponsor:** Tao OUYANG
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05-05
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2021-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613560, "Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01613560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*